News|Articles|April 5, 2024
Digital Biomarkers Solution shows pathway to reduced clinical trial sample sizes, shorter durations
Author(s)Roche
Digital biomarkers provide a pathway to the future where clinical trial sponsors can potentially benefit from reduced trial duration and sample size. Learn more about these benefits from a simulated study.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
If You Build It ... Will They Come?
2
Congressional Funding Deal Boosts Research Space Ahead of Shutdown Deadline
3
FDA RWE Guidance Redefines Data Use in Clinical Operations
4
The Business Case for DEI in Pharmaceutical Innovation: Why Organizational Commitment Matters for Inclusive Clinical Trials
5